Skip to content

Jazz Pharmaceuticals JAZZ Other operating expenses

Other operating expenses at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
-1.1%
Biogen logo
BiogenBIIB
Nuvalent, Inc. logo
Nuvalent, Inc.NUVL
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD

Other financials

Income statement

See full
Revenue$1.1B+19.1%
Operating income$336.6M+702%
Net income$293.1M+417%
EPS (diluted)$4.43+391%

Balance sheet

See full
Cash & equivalents$667.5M-64.1%
Total debt$5.4B-0.1%
Total equity$4.5B+8.6%
Total assets$11.9B+2.8%

Cash flow

See full
Operating cash flow$408.2M-5.0%
CapEx$19.7M+41.7%
Free cash flow$388.5M-6.6%

Valuation

See full
Market cap$14.11B+54.4%
Enterprise value$18.85B+47.7%
P/S3.2×+0.9×

Profitability

See full
Operating margin-11.9%-28.1pp
Net margin-8.9%-20.5pp
FCF margin28.6%-8.6pp

Returns & leverage

See full
Return on equity-9.1%-21.2pp
Debt / equity1.2×-0.1×
Current ratio-1.3×

Where this comes from

Reported directly by Jazz Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther.

The official record: Jazz Pharmaceuticals’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Jazz Pharmaceuticals's other operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Jazz Pharmaceuticals's other operating expenses?
Jazz Pharmaceuticals (JAZZ) reported other operating expenses of -0.2% in Q4 2025.
What does other operating expenses mean?
General business expenses not classified in other major categories.
How do you interpret other operating expenses?
Rising operating expenses relative to revenue may indicate declining operational efficiency.
How does other operating expenses compare across companies?
Varies significantly by industry; should be analyzed as a percentage of total revenue.